NantHealth, Inc. Financial Ratios — NHIQ Stock

Profitability (USD)

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Return on Common Equity (%)	- -	-57.64	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-19.92	-33.58	-30.91	-52.25	-22.71	-24.13	-29.27	-37.93
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	28.57	55.2	45.14	52.1	50.52	55.91	60.06	55.61	56.96
EBITDA Margin (%)	-130.75	-62.17	-111.38	-45.97	-31.68	-10.45	-11.98	-40.19	-52.74
Operating Margin (%)	-178.44	-96.36	-149.85	-78.34	-56.67	-39.33	-34.9	-65.28	-76.61
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-249.44	-98.1	-204.37	-154.14	-216.97	-85.76	-120.25	-93.33	-101.63
Profit Margin (%)	-248.89	-155.95	-228.97	-202.14	-214.78	-81.06	-76.98	-92.99	-101.16
Net Income to Common Margin (%)	-248.89	-155.95	-228.97	-202.14	-214.78	-81.06	-76.98	-92.99	-101.16
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	-57.64	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Total Debt	35	- -	191	195	200	218	223	258	267
ST Debt	35	- -	- -	- -	- -	2	102	3	3
LT Debt	- -	- -	191	195	200	216	121	256	265
Total Debt/EBITDA	-0.78	- -	-2.13	-4.91	-7.07	-26.91	-25.43	-10.27	-7.57
Net Debt/EBITDA	-0.69	0.21	-0.37	-3.36	-6.43	-24.86	-21.69	-8.79	-7.34
Total Debt/EBIT	-0.57	- -	-1.59	-2.88	-3.95	-7.15	-8.73	-6.32	-5.21
Net Debt/EBIT	-0.51	0.13	-0.28	-1.97	-3.59	-6.61	-7.45	-5.41	-5.06
EBITDA to Interest Expense	-45.26	-45.79	-13.93	-2.46	-1.66	-0.45	-0.46	-1.74	-2.5
EBITDA-CapEx/Interest Expense	-57.13	-66.91	-16.38	-3.31	-2.27	-0.7	-0.75	-2.09	-2.96
EBIT to Interest Expense	-61.77	-70.97	-18.74	-4.2	-2.96	-1.69	-1.33	-2.82	-3.64
Interest Expense	1	1	6	16	17	18	19	14	14
Common Equity/Total Assets	20.83	44.93	-69.44	-154.33	-308.77	-355.32	-500.88	-532.22	-702.39
Long-Term Debt/Equity (%)	- -	- -	46.41	101.12	7,081.49	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	-67.22	-39.27	-29.33	-29.61	-15.5	-32.2	-31.03
Long-Term Debt/Total Assets (%)	- -	- -	27.91	43.51	70.01	81.02	60.33	129.3	165.93
Total Debt/Equity (%)	53.24	- -	46.41	101.12	7,081.49	-381.13	-200.17	-159.56	-118.64
Total Debt/Capital (%)	34.76	- -	-67.22	-39.27	-29.33	-29.87	-28.6	-32.54	-31.34
Total Debt/Total Assets (%)	11.1	- -	27.91	43.51	70.01	81.72	111.34	130.66	167.6
Net Debt to Equity	47.53	-3.24	8.13	69.22	6,434.9	-352.1	-170.68	-136.57	-115.13
Net Debt/Capital (%)	32.24	-3.34	-7.58	-23.92	-25.95	-27.39	-23.69	-26.87	-30.35
EBITDA	-44	-29	-90	-40	-28	-8	-9	-25	-35
EBITDA-CapEx	-56	-42	-105	-53	-39	-13	-14	-30	-42
Operating Income (Loss)	-61	-44	-120	-68	-51	-30	-26	-41	-51

Liquidity (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Cash Ratio	2.59	0.17	2.75	1.72	0.5	0.09	0.18	1.04	0.05
Current Ratio	2.68	0.76	3.24	2.28	1.08	0.66	0.25	1.41	0.35
Quick Ratio	2.63	0.52	2.97	2.06	0.96	0.5	0.22	1.27	0.26
CFO/Avg Current Liab	- -	-1.14	-1.41	-1.74	-0.82	-0.19	-0.18	-0.36	-1.01
Common Equity/Total Assets	20.83	44.93	-69.44	-154.33	-308.77	-355.32	-500.88	-532.22	-702.39
Long-Term Debt/Equity (%)	- -	- -	46.41	101.12	7,081.49	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	-67.22	-39.27	-29.33	-29.61	-15.5	-32.2	-31.03
Long-Term Debt/Total Assets (%)	- -	- -	27.91	43.51	70.01	81.02	60.33	129.3	165.93
Total Debt/Equity (%)	53.24	- -	46.41	101.12	7,081.49	-381.13	-200.17	-159.56	-118.64
Total Debt/Capital (%)	34.76	- -	-67.22	-39.27	-29.33	-29.87	-28.6	-32.54	-31.34
Total Debt/Total Assets (%)	11.1	- -	27.91	43.51	70.01	81.72	111.34	130.66	167.6
CFO/Total Liabilities	-17.12	-32.61	-25.89	-31.71	-10.45	-2.71	-5.41	-7.7	-8.38
CFO/CapEx	-3.62	-5.59	-4.48	-5.95	-2.81	-1.91	-2.97	-5.45	-4.99
Altman's Z-Score	-1.21	-1.73	0.75	-3.14	-12.29	-11.48	-27.62	-25.15	-54.57

Working Capital (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Accounts Receivable Turnover	- -	6.64	6.95	7.48	6.68	7.21	15.48	13.79	11.4
Days Sales Outstanding	- -	54.99	52.53	48.77	54.62	50.59	23.57	26.46	32.03
Inventory Turnover	- -	8.13	23.03	32.9	66.32	52.76	73.25	- -	- -
Days Inventory Outstanding	- -	44.92	15.85	11.09	5.5	6.92	4.98	- -	- -
Accounts Payable Turnover	- -	3.76	6.99	8.84	18.25	13.7	6.69	6.68	4.24
Accounts Payable Turnover Days	- -	97.11	52.21	41.29	20	26.64	54.56	54.64	86.14
Cash Conversion Cycle	- -	2.79	16.18	18.58	40.13	30.87	-26	-28.19	-54.11
Inventory to Cash Days	- -	10.07	36.68	37.68	49.12	43.68	18.59	26.46	32.03
Inventories	3	2	2	1	- -	1	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	1	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	3	2	1	1	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Market Capitalization	- -	- -	1,109	356	59	114	358	120	28
- Cash & Cash Equivalents	4	6	158	62	18	5	23	29	2
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	35	- -	191	195	200	218	223	258	267
Enterprise Value	-191	-7	1,143	490	242	326	559	350	294
Total Capital	99	185	-284	-498	-684	-729	-780	-794	-853
Total Debt/Capital (%)	34.76	- -	-67.22	-39.27	-29.33	-29.87	-28.6	-32.54	-31.34
Total Debt / EV	-0.18	- -	0.17	0.4	0.83	0.67	0.4	0.74	0.91
EV/Sales	- -	- -	14.21	5.65	2.7	4.21	7.64	5.58	4.38
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	36.23	228.85	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	24	68.89	- -	- -
Diluted Market Cap	- -	- -	1,109	356	59	114	358	120	28
Diluted Enterprise Value	31	-6	1,143	490	242	326	559	350	294
EV per Share	- -	- -	153.6	62.94	33.19	44.34	75.57	45.97	38.14
TTM Sales	34	46	80	87	89	77	73	63	67
TTM EBITDA	-44	-29	-90	-40	-28	-8	-9	-25	-35
TTM Operating Income	-61	-44	-120	-68	-51	-30	-26	-41	-51
TTM Cash Flow to Firm	-41	-73	-65	-65	-13	9	2	-13	-18
TTM Free Cash Flow to Firm	-30	-60	-49	-52	-2	14	8	-8	-12

Multiples (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Price/Free Cash Flow	- -	- -	-20.22	-5.27	-3.11	-27.25	-32.05	-5.33	-1.09
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-191	-7	1,143	490	242	326	559	350	294
Low Price	- -	- -	144.15	39	7.26	6.75	13.8	13.82	1.57
EV/Sales	- -	- -	14.21	5.65	2.7	4.21	7.64	5.58	4.38
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-7.51	-3.08	-1.47	-1.29	-5.2	-4.83	-0.95
Price/Earnings High	- -	- -	-12.73	-7.24	-2.3	-3.45	-13	-10.68	-1.91
Price/Earnings Low	- -	- -	-5.83	-1.73	-0.27	-0.79	-1.81	-1.81	-0.18
Price/Book Value	- -	- -	-2.33	-0.51	-0.07	-0.12	-0.36	-0.11	-0.03
Price/Book Value Average	- -	- -	-2.91	-0.78	-0.32	-0.09	-0.29	-0.27	-0.06
Price/Book Value High	- -	- -	-4.93	-1.83	-0.5	-0.23	-0.73	-0.59	-0.12
Price/Book Value Low	- -	- -	-2.26	-0.44	-0.06	-0.05	-0.1	-0.1	-0.01
Price/Tangible Book Value	- -	- -	5.08	38.48	-0.33	-0.55	-1.39	-0.4	-0.08
Price/Tangible Book Value Average	- -	- -	6.34	58.38	-1.59	-0.39	-1.14	-0.94	-0.18
Price/Tangible Book Value High	- -	- -	10.74	137.14	-2.49	-1.05	-2.84	-2.08	-0.37
Price/Tangible Book Value Low	- -	- -	4.92	32.8	-0.3	-0.24	-0.4	-0.35	-0.03
Price/Sales	- -	- -	13.8	4.11	0.66	1.47	4.9	1.92	0.42
Price/Sales Average	- -	- -	17.19	6.23	3.15	1.04	4	4.49	0.96
Price/Sales High	- -	- -	29.15	14.64	4.94	2.79	10.01	9.93	1.93
Price/Sales Low	- -	- -	13.34	3.5	0.59	0.64	1.4	1.68	0.18
Price/Cash Flow	- -	- -	-15.71	-4.39	-2	-12.97	-21.26	-4.35	-0.87
Price/Cash Flow Average	- -	- -	-19.57	-6.66	-9.52	-9.22	-17.37	-10.16	-1.99
Price/Cash Flow High	- -	- -	-33.18	-15.64	-14.92	-24.68	-43.45	-22.47	-4.01
Price/Cash Flow Low	- -	- -	-15.18	-3.74	-1.78	-5.67	-6.06	-3.8	-0.37
Price/Free Cash Flow Average	- -	- -	-25.2	-8	-14.78	-19.37	-26.17	-12.45	-2.49
Price/Free Cash Flow High	- -	- -	-42.72	-18.8	-23.17	-51.86	-65.49	-27.52	-5.02
Price/Free Cash Flow Low	- -	- -	-19.55	-4.5	-2.77	-11.91	-9.13	-4.65	-0.47
EV/Sales Average	0.91	- -	17.61	7.78	5.19	3.79	6.74	8.15	4.92
EV/Sales High	0.91	- -	29.56	16.18	6.98	5.54	12.75	13.59	5.9
EV/Sales Low	0.91	- -	13.75	5.05	2.63	3.39	4.14	5.34	4.15
EV/EBITDA Average	-0.69	0.21	-15.81	-16.91	-16.38	-36.25	-56.26	-20.29	-9.33
EV/EBITDA High	-0.69	0.21	-26.54	-35.2	-22.02	-52.99	-106.4	-33.82	-11.18
EV/EBITDA Low	-0.69	0.21	-12.35	-10.98	-8.29	-32.4	-34.52	-13.29	-7.86
EV/EBIT Average	-0.51	0.13	-11.75	-9.93	-9.16	-9.63	-19.32	-12.49	-6.43
EV/EBIT High	-0.51	0.13	-19.73	-20.66	-12.31	-14.08	-36.53	-20.82	-7.7
EV/EBIT Low	-0.51	0.13	-9.18	-6.44	-4.64	-8.61	-11.85	-8.18	-5.41
Last Price	- -	- -	149.1	45.75	8.16	15.45	48.45	15.83	3.65
High Price	- -	- -	315	163.05	60.75	29.4	99	81.75	16.8
Enterprise Value Average	31	-6	1,416	674	464	293	493	511	330
Enterprise Value High	31	-6	2,377	1,403	624	429	933	852	395
Enterprise Value Low	31	-6	1,106	437	235	262	303	335	278

Shares Outstanding	8	8	8	7	7	7	7	8	8
Diluted Weighted Avg Shares	8	8	7	8	7	7	7	8	8
Basic Weighted Avg Shares	8	8	7	8	7	7	7	8	8
Revenue per Share	4.21	5.74	10.81	11.14	12.29	10.52	9.89	8.23	8.7
EBITDA per Share	-5.51	-3.57	-12.04	-5.12	-3.89	-1.1	-1.19	-3.31	-4.59
Operating Income per Share	-7.52	-5.53	-16.19	-8.72	-6.97	-4.14	-3.45	-5.37	-6.66
Basic EPS, GAAP	-10.49	-8.95	-24.74	-22.51	-26.4	-8.53	-7.61	-7.66	-8.8
Basic EPS from Cont Ops	-10.51	-5.68	-18.89	-16.88	-26.17	-8.89	-11.96	-7.7	-8.8
Diluted EPS, GAAP	-10.49	-8.95	-24.74	-22.51	-26.4	-8.52	-7.61	-7.66	-8.8
Diluted EPS from Cont Ops	-10.51	-5.68	-18.89	-16.88	-26.17	-8.88	-11.96	-7.7	-8.8
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-5.23	-9.19	-9.49	-10.43	-4.07	-1.19	-2.28	-3.64	-4.19
Free Cash Flow per Basic Share	-6.68	-10.84	-11.61	-12.18	-5.52	-1.82	-3.05	-4.31	-5.03
Cash & Equivalents per Share	28.03	0.9	21.18	7.92	2.52	0.71	3.08	3.82	0.23
Book Value per Share	8.04	23	-63.88	-89.07	-121.48	-128.71	-135.62	-138.36	-145.49
Tangible Book Value per Share	-0.13	9.11	29.32	1.19	-24.43	-28.04	-34.84	-39.34	-45.94

NantHealth, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)